Press Releases concerning clinical trial results are intended to inform interested parties of the advancements of laser technology in process, not to imply new indications for use. Erchonia supports only those indications for use, cleared by the FDA via 510(k).
McKinney, TX (PRWEB) April 22, 2014
Erchonia today announces that the preliminary results of an ongoing clinical trial testing its Lunula laser for the noninvasive treatment of nail fungus have been published in the latest issue of the medical journal Podiatry Review.
Model Wins a Trip to Florida, $5,000 cash and Stars in Zerona’s 2012 Marketing Campaign